Pharmaceutical companies are constantly evaluating the appropriate balance and presentation of risk and benefit information within promotional material. This has proved to be a constant challenge for pharmaceutical companies in regards to certain types of promotional material. This session will discuss some of the recent developments regarding how a product’s risk information could be communicated- with a focus on the presentation of risk information in materials directed towards consumers.
Learning Objective : Upon completion of this session, the participant should be able to:
Review historical disclosure of risk information in consumer directed advertising
Evaluate a study designed to assess an alternative approach to presenting risk information within broadcast direct-to-consumer (DTC) prescription drug ads
Discuss the pros and cons of a potential new risk presentation within broadcast DTC prescription drug ads